Next-Gen Biologics

What do you see as the next big modality in biologics, and what factors are driving innovation in this space?

Pharma's Almanac

AI

Is AI truly transforming drug development, or are we still navigating through the hype?

Pharma's Almanac

Supply Chain

What strategies are ensuring supply chain resilience in a post-COVID world?

Pharma's Almanac

BIOSECURE Act

Can you discuss the anticipated impacts of the BIOSECURE Act on the biopharmaceutical landscape?

Pharma's Almanac

Digitalization

How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?

Pharma's Almanac

Investment

What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction?

Pharma's Almanac

Accelerating Product Development

What strategies are being employed to accelerate product development and commercialization without compromising quality?

Pharma's Almanac

Roundtable

What do you see as the most significant regulatory decision or guidance on the horizon for 2024 (or beyond)?

Pharma's Almanac

Roundtable

What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?

Pharma's Almanac

Integration

Creating Value through Best Practices Across a Global, Integrated Service Provider

Jeffrey Butler, Ph.D.

AMPAC Fine Chemicals

Innovation

Creating a Global CDMO Focused on Quality, Innovation and Happiness

Aslam Malik, Ph.D.

SK pharmteco